🟠 Moderate Evidence
Although commonly classified as a vitamin, emerging biochemical evidence shows that vitamin D functions as a steroid hormone, regulating over 200 genes and influencing immune function, bone metabolism, cell proliferation, and calcium homeostasis across multiple organ systems. Rather than a simple micronutrient, vitamin D operates as a systemic endocrine signaling molecule that coordinates critical physiological pathways from the skin to the nucleus.
Key takeaways
- Vitamin D is classified biochemically as a steroid hormone, not a simple vitamin, due to its role in gene regulation and endocrine signaling
- The conversion pathway involves three organs—skin, liver, and kidneys—and produces an active hormone, 1,25-dihydroxyvitamin D₃, that controls hundreds of cellular processes
- Vitamin D receptors are present in nearly every cell type, including immune cells, bone osteoblasts, thyroid tissue, and the brain, enabling systemic regulation
- Immune cells can independently activate vitamin D locally, making serum vitamin D status a critical determinant of immunological response
Vitamin D Conversion Pathway: From Skin to Active Hormone
Multi-organ system showing sequential activation of vitamin D through liver and kidney, resulting in the active steroid hormone
Source: Endocrine Society, Clinical Practice Guidelines on Vitamin D (2011) | Georgian Medical Journal News
The Three-Organ Activation System
The conversion of vitamin D from sunlight exposure to its active hormonal form is a coordinated multi-organ process fundamentally different from simple vitamin metabolism. When UVB radiation (wavelength 290–315 nm) penetrates the skin, it triggers isomerization of 7-dehydrocholesterol into previtamin D₃, a photochemical reaction that only occurs with specific ultraviolet wavelengths. The skin cannot complete the activation; instead, this precursor enters circulation and is transported to the liver, where it undergoes hydroxylation to form 25-hydroxyvitamin D [25(OH)D₃], the major circulating form that clinicians measure in diagnostic blood tests.
The kidney is the critical second activation site. The enzyme 1α-hydroxylase in proximal tubule cells performs the final, rate-limiting conversion to 1,25-dihydroxyvitamin D₃ [1,25(OH)₂D₃], the fully active steroid hormone. This conversion is tightly regulated by parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), serum phosphate, and serum calcium—feedback loops characteristic of endocrine hormone regulation, not vitamin metabolism. Notably, immune cells, including activated macrophages and dendritic cells, express 1α-hydroxylase and can generate active vitamin D locally without renal involvement, meaning vitamin D status directly influences local immunological responses.
Systemic Endocrine Signaling: Vitamin D Receptors Throughout the Body
The presence of vitamin D receptors (VDR) in nearly every tissue—including osteoblasts, lymphocytes, thyroid follicular cells, parathyroid cells, intestinal enterocytes, vascular endothelium, and neurons—distinguishes vitamin D from traditional vitamins and places it squarely within the steroid hormone family. The active hormone, 1,25(OH)₂D₃, binds to these VDRs in the cytoplasm, forms a heterodimer with the retinoid X receptor (RXR), translocates to the nucleus, and regulates transcription of target genes containing vitamin D-responsive elements (VDREs) in their promoter regions.
Research from the Endocrine Society demonstrates that vitamin D controls expression of genes involved in immune tolerance, antimicrobial peptide synthesis (cathelicidin and β-defensin), osteocalcin production in bone, parathyroid hormone suppression, intestinal calcium-binding proteins, and cell-cycle regulatory proteins. This breadth of genomic action—affecting immunity, skeletal health, mineral homeostasis, cell proliferation, and inflammation—defines the vitamin D system as an endocrine network rather than a simple nutritional pathway. The finding that vitamin D promotes differentiation of regulatory T cells and inhibits pathogenic Th17 cell responses through VDR signaling in immune cells illustrates how serum vitamin D concentration directly modulates adaptive immunity—a hallmark of hormonal rather than nutritional regulation.
Clinical and Physiological Implications of Vitamin D Deficiency
Understanding vitamin D as a hormone rather than a vitamin reframes deficiency from a simple micronutrient gap to a systemic endocrine insufficiency. Serum 25(OH)D₃ levels below 20 ng/mL (50 nmol/L) are classified as deficiency by the Endocrine Society Clinical Practice Guidelines, and accumulating epidemiological evidence links deficiency to elevated risk of rickets in children, secondary hyperparathyroidism, accelerated bone loss, impaired immune competence, and increased susceptibility to infections. The mechanistic basis—loss of 1,25(OH)₂D₃-mediated VDR signaling in immune cells, reduced intestinal calcium absorption, and PTH dysregulation—demonstrates that vitamin D deficiency disrupts fundamental homeostatic networks.
Observational data suggest associations between low vitamin D status and increased incidence of respiratory tract infections, autoimmune diseases (including multiple sclerosis and type 1 diabetes), and certain malignancies, though randomized controlled trials on vitamin D supplementation for disease prevention remain mixed, indicating that the transition from biochemical understanding to clinical prevention remains an active area of investigation.
Vitamin D is a steroid hormone controlling over 200 genes across immune, skeletal, endocrine, and neurological systems through VDR-mediated gene transcription, not a simple micronutrient supporting single metabolic function.
— Endocrine Society Clinical Practice Guidelines (2011)
What this means
Ensuring adequate vitamin D status (serum 25(OH)D ≥30 ng/mL) through sun exposure, dietary sources (fatty fish, fortified milk), or supplementation is a modifiable endocrine health factor, particularly important for immune competence, bone health, and prevention of secondary hyperparathyroidism. Individual requirements vary with latitude, skin pigmentation, age, and kidney function.
Vitamin D deficiency should be treated as endocrine insufficiency rather than simple nutritional correction. Risk assessment, baseline 25(OH)D measurement, and monitoring of mineral metabolism (serum calcium, phosphate, PTH) are warranted, especially in populations at high risk (older adults, dark-skinned individuals in northern latitudes, patients with chronic kidney disease, and those with malabsorption disorders). Referral to endocrinology may be appropriate for refractory secondary hyperparathyroidism.
Recognition of vitamin D as an endocrine rather than nutritional issue supports public health strategies including voluntary fortification of milk and plant-based beverages, screening guidelines for at-risk populations, and education campaigns emphasizing safe sun exposure and dietary sources. Healthcare systems should integrate vitamin D assessment into routine care for chronic disease management and immunological health.
Frequently asked questions
Why is vitamin D called both a vitamin and a hormone?
Vitamin D is a historical misnomer. Early nutritionists classified it as a vitamin because deficiency causes rickets (similar to other avitaminoses), but biochemically it is a steroid hormone. It is fat-soluble, synthesized in the body from sunlight, and critically regulates gene expression through nuclear receptor binding—all hallmarks of steroid hormones (cortisol, testosterone, estrogen). The dual terminology persists due to historical convention and regulatory classification, but endocrinologists now classify vitamin D as a hormone.
What serum vitamin D level is considered sufficient?
The Endocrine Society defines serum 25(OH)D of 30 ng/mL (75 nmol/L) or higher as sufficient for skeletal and general health in healthy adults, with 20–29 ng/mL classified as insufficient and below 20 ng/mL as deficiency. However, optimal levels for immune function and other extra-skeletal effects remain debated; some experts advocate for levels of 40–60 ng/mL for comprehensive health benefits, though evidence from randomized trials is still emerging.
Can I get enough vitamin D from sun exposure alone?
Sun exposure is a primary source of vitamin D (skin synthesis accounts for 80–90% of total vitamin D in populations with adequate outdoor time), but synthesis depends on latitude, season, time of day, skin pigmentation, and age. In northern latitudes (above 35°N) during winter months, UVB radiation is insufficient for skin synthesis. Individuals with darker skin require 3–10 times longer sun exposure than lighter-skinned individuals. Dietary sources (fatty fish, egg yolks, fortified dairy) and supplementation are recommended as complementary strategies, particularly for at-risk populations. See clinical guidance on nutrition for personalized recommendations.
The reclassification of vitamin D from nutrient to hormone reflects decades of molecular and clinical research demonstrating its role as a central regulator of human physiology. As understanding of vitamin D’s extra-skeletal effects—particularly immune modulation and cancer-protective pathways—continues to deepen, clinical practice and public health approaches will likely evolve toward more proactive vitamin D screening and management across healthcare systems, particularly in populations at high risk of deficiency.
Source: Vitamin D hormone mechanism infographic and biochemical pathways summary
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
